Riskpilot← Back to searchSign inGet full accessMedikon Oy
OYActiveY-tunnus 2405134-7Näsin Koulukatu 2Medical specialists activities · NACE 8622Est. 2011— employees
Revenue 2024
EUR 239K
+470% vs 2023
EBITDA margin
21.0%
-23% vs 2023
Equity ratio
69.9%
Financial strength
Net profit 2024
EUR 21K
-42% vs 2023
| Revenue | EUR 239K | +470% |
| EBITDA | EUR 50K | -23% |
| Net profit | EUR 21K | -42% |
| Total assets | EUR 216K | +3% |
| Equity | EUR 151K | +7% |
| Employees | — | — |
Legal name
Medikon Oy
Y-tunnus number
2405134-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
27. huhtikuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveyspalvelujen tuottaminen ja vuokraus.
Address
Näsin Koulukatu 2
Phone
+3580195246422
Email
tapani.kontio@medius.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 198 | 213 | 188 | 42 | 239 |
| Staff expenses | −184 | −183 | −130 | −148 | −164 |
| EBITDA | 39 | 68 | 31 | 65 | 50 |
| Depreciation & amort. | −9 | −21 | −6 | −16 | −20 |
| EBIT | 30 | 46 | 25 | 49 | 31 |
| Net financials | −1 | −1 | −1 | −3 | −3 |
| Profit before tax | 29 | 45 | 24 | 47 | 27 |
| Tax | 6 | 9 | 5 | 10 | 6 |
| Net profit | 23 | 36 | 19 | 37 | 21 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 122 | 213 | 190 | 210 | 216 |
| Equity | 68 | 103 | 114 | 141 | 151 |
| Long-term debt | 31 | 74 | 63 | 52 | 41 |
| Short-term debt | 23 | 36 | 14 | 17 | 24 |
| Total debt | 54 | 110 | 77 | 69 | 65 |
EBITDA margin
21.0%
This company
15.8%
Market median
+33% vs market
20202024
Equity ratio
69.9%
This company
38.2%
Market median
+83% vs market
20202024
Return on equity
14.2%
This company
18.4%
Market median
+23% vs market
20202024
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20202024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JA Deputy Member | Deputy Member | 2011 |
CJ | Audit | 2025 |
VM Deputy auditor | Deputy auditor | 2016 |
| Former (1) | ||
MG Audit | Audit | 2016 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medikon Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaana Anneli Kontio | Deputy Member | 0 companies |
| Mats Gunnar Green | Audit | 0 companies |
| Christoffer Johan Aarnio | Audit | 0 companies |
| Viveka Marlene Teresia Backman | Deputy auditor | 0 companies |
| Heikki Tapani Kontio | Board of Directors | 0 companies |